Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03800134 |
|---|---|
| Brief Title: | A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer (AEGEAN) |
| First Submitted : | December 7, 2018 |
| First Submitted that Met QC Criteria : | January 8, 2019 |
| First Posted : | January 11, 2019 |
| Last Update Submitted that Met QC Criteria : | April 17, 2023 |
| Last Update Posted : | April 18, 2023 |